Tilray Brands Price to Book Ratio 2017-2025 | TLRY
Historical price to book ratio values for Tilray Brands (TLRY) over the last 10 years. The current price to book ratio for Tilray Brands as of June 10, 2025 is 0.15.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Tilray Brands Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-06-10 | 0.42 | 0.15 | |
| 2025-02-28 | 0.74 | $2.77 | 0.26 |
| 2024-11-30 | 1.34 | $3.72 | 0.36 |
| 2024-08-31 | 1.71 | $3.98 | 0.43 |
| 2024-05-31 | 1.80 | $4.14 | 0.43 |
| 2024-02-29 | 1.73 | $4.32 | 0.40 |
| 2023-11-30 | 1.81 | $4.63 | 0.39 |
| 2023-08-31 | 2.96 | $4.70 | 0.63 |
| 2023-05-31 | 1.67 | $5.07 | 0.33 |
| 2023-02-28 | 2.83 | $5.51 | 0.51 |
| 2022-11-30 | 3.87 | $7.31 | 0.53 |
| 2022-08-31 | 3.80 | $7.59 | 0.50 |
| 2022-05-31 | 4.49 | $8.34 | 0.54 |
| 2022-02-28 | 6.10 | $9.70 | 0.63 |
| 2021-11-30 | 10.12 | $9.64 | 1.05 |
| 2021-08-31 | 13.69 | $9.73 | 1.41 |
| 2021-05-31 | 16.67 | $10.00 | 1.67 |
| 2021-03-31 | 22.73 | $3.02 | 7.53 |
| 2021-02-28 | 24.36 | 0.00 | |
| 2020-12-31 | 8.26 | 0.00 | |
| 2020-11-30 | 9.04 | 0.00 | |
| 2020-09-30 | 4.85 | $1.40 | 3.46 |
| 2020-08-31 | 6.71 | 0.00 | |
| 2020-06-30 | 7.11 | $1.04 | 6.81 |
| 2020-03-31 | 6.88 | $1.53 | 4.51 |
| 2019-12-31 | 17.13 | 0.00 | |
| 2019-09-30 | 24.74 | $4.46 | 5.54 |
| 2019-06-30 | 46.56 | $3.70 | 12.59 |
| 2019-03-31 | 65.52 | $3.95 | 16.61 |
| 2018-12-31 | 70.54 | $2.12 | 33.25 |
| 2018-09-30 | 143.62 | $2.02 | 71.13 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.413B | $0.789B |
| Tilray Brands Inc. is a cannabis-lifestyle and consumer packaged goods company. It operates principally in Canada, the United States, Europe, Australia and Latin America. Tilray Brands Inc., formerly known as Tilray Inc., is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $232.094B | 27.91 |
| Boston Scientific (BSX) | United States | $148.004B | 37.05 |
| Stryker (SYK) | United States | $145.912B | 30.51 |
| EssilorLuxottica (ESLOY) | France | $130.051B | 0.00 |
| Medtronic (MDT) | Ireland | $112.158B | 15.90 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.407B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.971B | 27.90 |
| ResMed (RMD) | United States | $36.801B | 27.64 |
| Agilent Technologies (A) | United States | $33.162B | 21.62 |
| GE HealthCare Technologies (GEHC) | United States | $32.817B | 15.58 |
| Terumo (TRUMY) | Japan | $26.665B | 34.63 |
| Koninklijke Philips (PHG) | Netherlands | $22.070B | 15.86 |
| Insulet (PODD) | United States | $21.511B | 84.44 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.366B | 11.80 |
| Baxter (BAX) | United States | $15.831B | 11.82 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.086B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.076B | 0.00 |
| Demant (WILYY) | Denmark | $8.854B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.138B | 21.36 |
| Lantheus Holdings (LNTH) | United States | $5.758B | 14.52 |
| Prestige Consumer Healthcare (PBH) | United States | $4.234B | 18.91 |
| Perrigo (PRGO) | Ireland | $3.598B | 9.12 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.442B | 15.68 |
| ICU Medical (ICUI) | United States | $3.353B | 24.73 |
| Envista Holdings (NVST) | United States | $3.224B | 26.79 |
| GN Store Nord (GNNDY) | Denmark | $2.180B | 18.06 |
| QuidelOrtho (QDEL) | United States | $2.043B | 14.05 |
| LeMaitre Vascular (LMAT) | United States | $1.883B | 42.08 |
| AtriCure (ATRC) | United States | $1.692B | 0.00 |
| Acuren (TIC) | United States | $1.348B | 0.00 |
| Neogen (NEOG) | United States | $1.198B | 15.33 |
| AdaptHealth (AHCO) | United States | $1.190B | 12.08 |
| BioLife Solutions (BLFS) | United States | $1.132B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.087B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.082B | 24.33 |
| Phibro Animal Health (PAHC) | United States | $0.982B | 12.55 |
| InMode (INMD) | Israel | $0.920B | 9.27 |
| CeriBell (CBLL) | United States | $0.644B | 0.00 |
| Evolus (EOLS) | United States | $0.622B | 0.00 |
| Owens & Minor (OMI) | United States | $0.613B | 5.08 |
| Capricor Therapeutics (CAPR) | United States | $0.611B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.581B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.581B | 0.00 |
| Valneva SE (VALN) | France | $0.517B | 0.00 |
| Surmodics (SRDX) | United States | $0.417B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.351B | 12.91 |
| SNDL (SNDL) | Canada | $0.349B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.327B | 58.20 |
| Canopy Growth (CGC) | Canada | $0.298B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.291B | 0.00 |
| Cerus (CERS) | United States | $0.281B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.272B | 22.90 |
| Cresco Labs (CRLBF) | United States | $0.263B | 0.00 |
| ZimVie (ZIMV) | United States | $0.261B | 11.89 |
| Sanara MedTech (SMTI) | United States | $0.258B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.258B | 0.00 |
| Omeros (OMER) | United States | $0.221B | 0.00 |
| Biote (BTMD) | United States | $0.215B | 6.05 |
| OraSure Technologies (OSUR) | United States | $0.214B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.212B | 0.00 |
| Brainsway (BWAY) | Israel | $0.208B | 55.05 |
| Quanterix (QTRX) | United States | $0.196B | 0.00 |
| High Tide (HITI) | Canada | $0.191B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.185B | 15.08 |
| Organigram Global (OGI) | Canada | $0.185B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.184B | 0.00 |
| Exagen (XGN) | United States | $0.153B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.133B | 16.40 |
| Vireo Growth (VREOF) | United States | $0.129B | 0.00 |
| Jin Medical (ZJYL) | China | $0.107B | 0.00 |
| MacroGenics (MGNX) | United States | $0.103B | 0.00 |
| Veru (VERU) | United States | $0.095B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.094B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| Fonar (FONR) | United States | $0.089B | 11.50 |
| TerrAscend (TSNDF) | Canada | $0.083B | 0.00 |
| Agape ATP (ATPC) | $0.075B | 0.00 | |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.068B | 0.00 |
| Zynex (ZYXI) | United States | $0.066B | 0.00 |
| Apyx Medical (APYX) | United States | $0.065B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.058B | 0.00 |
| Modular Medical (MODD) | United States | $0.044B | 0.00 |
| Nephros (NEPH) | United States | $0.040B | 54.43 |
| United-Guardian (UG) | United States | $0.038B | 13.25 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Safety Shot (SHOT) | United States | $0.020B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.016B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |